title: Cytokeratin expression in squamous metaplasia of the human uterine cervix.
abstract: The expression of cytokeratin polypeptides in squamous metaplasia of the human uterine cervix was investigated by immunocytochemical labeling with polypeptide-specific antibodies against cytokeratins. Immunofluorescence microscopic examination of cervical tissues using various monoclonal antibodies indicated that squamous cervical metaplasia expresses a unique set of cytokeratin polypeptides, this being distinctively different from that expressed by all of the normal epithelial elements of the exo- and endocervix. The development of metaplastic foci was accompanied by the expression of cytokeratin polypeptide no. 13, which is commonly detected in stratified epithelia, and by a reduction in the level of polypeptide no. 18, which is typical of simple epithelia. The 40-kilodalton cytokeratin (no. 19) described by Moll et al., which is abundant in the columnar and reserve cells of the endocervix, was found throughout the metaplastic lesions. Only in 'well-differentiated' metaplasias did we detect polarity of cytokeratin expression reminiscent of the staining patterns in the exocervix. This was manifested by the exclusive labeling of the basal cell layer(s) with antibodies KB 8.37 and KM 4.62, which stain the basal cells of the exocervix. Furthermore, a comparison of cervical metaplasia with squamous areas occurring within endometrial adenocarcinomas pointed to a close similarity in the cytokeratin expression of the two. We discuss the use of cytokeratins as specific markers of squamous differentiation, the relationships between squamous metaplasia and cervical neoplasia, and the involvement of reserve cells in the metaplastic process.
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D002584:Cervix Uteri / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D003101:Collodion; D004591:Electrophoresis, Polyacrylamide Gel; D004848:Epithelium / Q000032:analysis; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007633:Keratins / Q000032:analysis* / Q000276:immunology / Q000502:physiology; D008679:Metaplasia / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D010455:Peptides / Q000032:analysis / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000503:physiopathology
chemical_list: D000911:Antibodies, Monoclonal; D010455:Peptides; D007633:Keratins; D003101:Collodion